Jump to ContentJump to Main Navigation
Show Summary Details

Nanotube Therapy

1 Issue per year

DE GRUYTER OPEN

Emerging Science

Open Access

    Open Access
    Online
    ISSN
    2299-1026
    See all formats and pricing
    More options …

    Overview

    "Nanotube Therapy" is closed for submissions effective September 1, 2013. It has been merged with "Nanomaterials and Tissue Regeneration". All authors are therefore invited to submit manuscripts at www.versita.com/ntr.


    Nanotube Therapy is focused on the chemistry, biology, and engineering involved in the application of nanotube technology for the improvement of human health. Material properties, novel devices, in vitro, in vivo, and clinical studies are all within the scope of the journal. We welcome papers utilizing nanotubes, nanorods, nanowires and nanohorns for targeted drug delivery, biomaterials, imaging contrast agents, point-of-care diagnostic assays, as examples. Of particular interest is research of a pre-clinical or translational nature that will have a clear impact on the diagnosis and treatment of human disease.

    Aims and Scope

    Why subscribe and read

    The goal of Nanotube Therapy is to feature high quality articles on nanotubes, nanorods, nanowires and nanohorns in medicine and biology, and serve as a hub integrating this research community. Nanotube biotechnology is by its nature a multidisciplinary research area, addressing issues and concepts of interest to physical scientists, biologists, engineers and clinicians.

    Details

    DE GRUYTER OPEN
    Emerging Science
    Language:
    English
    Type of Publication:
    Journal

    Submission of Manuscripts

    Instructions for Authors

    "Nanotube Therapy" is closed for submissions effective September 1, 2013. It has been merged with "Nanomaterials and Tissue Regeneration". All authors are therefore invited to submit manuscripts at www.versita.com/ntr.

    More ...

    Abstracting & Indexing

    Nanotube Therapy is covered by the following services:

    • Baidu Scholar
    • Case
    • Celdes
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC
    • EBSCO Discovery Service
    • Google Scholar
    • J-Gate
    • JournalTOCs
    • KESLI-NDSL (Korean National Discovery for Science Leaders)
    • Meta (formerly Sciencescape)
    • Naviga (Softweco)
    • Primo Central (ExLibris)
    • Publons
    • PubsHub
    • ReadCube
    • ResearchGate
    • Sherpa/RoMEO
    • Summon (Serials Solutions/ProQuest)
    • TDNet
    • Ulrich's Periodicals Directory/ulrichsweb
    • WanFang Data
    • WorldCat (OCLC)

    Editorial Information

    Journal Editors
    Michael R. King, Cornell University, USA

    Editorial Advisory Board
    Ji-Xin Cheng, Purdue University, USA
    WK Choi, National University of Singapore, Singapore
    Joseph Irudayaraj, Purdue University, USA
    Jin-Woo Kim, University of Arkansas, USA
    Luke Lee, University of California, Berkeley, USA
    Aihua Liu, Chinese Academy of Sciences, China
    Moein Moghimi, University of Copenhagen, Denmark
    Francesco Stellacci, EPFL, Switzerland
    Suzy V. Torti, Wake Forest University, USA
    Thomas Webster, Brown University, USA

    Assistant Editors
    Woojin Han, University of Pennsylvania, USA
    Andrew D. Hughes, Cornell University, USA
    Michael C. Mancini, Spectropath, Inc., USA

    Language Editors
    Nathan Alves, University of Notre Dame, USA
    Christopher G. Bailey, Naval Research Laboratory, USA
    Yue Geng, Cornell University, USA
    Nipa A. Mody, Johnson & Johnson, USA

    Contact

    Versita Ltd.
    ul. Bogumiła Zuga 32A
    01-811 Warsaw, Poland
    Phone: +48 22 701 50 15

    Comments (0)

    Please log in or register to comment.
    Log in